COMMUNIQUÉS West-GlobeNewswire

JSC Olainfarm Invites To Join Company’s Presentation At CEO Meets Investors Event In Riga
26/11/2018
JSC Olainfarm is inviting investors to join Olainfarm’s online presentation today at 11:45 (EET) at the annual CEO Meets Investor event in Riga. The presentation will be led by the Advisor to the Board of JSC Olainfarm [...]
Chi-Med Announces First Commercial Launch of Fruquintinib Capsules (Elunate®)
26/11/2018
LONDON, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announces the first commercial launch of fruquintinib capsules (Elunate ® ) with the initiation of product [...]
Telix Pharmaceuticals Acquires Advanced Nuclear Medicine Ingredients (ANMI) SA
26/11/2018
MELBOURNE, Australia, BRUSSELS and LIÈGE, Belgium, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the [...]
MDxHealth (R): MDxHealth Announces Approval for SelectMDx for Prostate Cancer by New York State
26/11/2018
NEWS RELEASE REGULATED INFORMATION IRVINE, CA, and HERSTAL, BELGIUM - 07.00 CET, 26 November 2018 - MDxHealth SA (Euronext: MDXH.BR) today announces that the New York State Department of Health has approved its [...]
MDxHealth (R) : MDxHealth annonce avoir reçu l'homologation de l'État de New York pour son test SelectMDx for Prostate Cancer
26/11/2018
COMMUNIQUÉ DE PRESSE INFORMATIONS RÉGLEMENTÉES IRVINE, CA, et HERSTAL, BELGIQUE - 07:00 CET, 26 novembre 2018 - MDxHealth SA (Euronext : MDXH.BR) annonce aujourd'hui avoir reçu l'homologation du département de la santé [...]
TLC to Attend Goldman Sachs Asia Pacific Healthcare Forum 2018
25/11/2018
TAIPEI, Taiwan and SOUTH SAN FRANCISCO, Calif., Nov. 25, 2018 (GLOBE NEWSWIRE) -- Taiwan Liposome Company, Ltd. (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company dedicated to the development [...]
Align Announces New iTero Updates and Connectivity to Improve Customer Experience and Workflow for Dental Practices
24/11/2018
New iTero software upgrade with enhanced functionality improves scan quality and patient privacy New iTero connectivity with exocad® and Dentrix® enhances both doctor and patient experience SAN JOSE, Calif., Nov. 23, [...]
ESPERITE (ESP): financial results for 2017 are published.
23/11/2018
Amsterdam, The Netherlands - 23 November 2018 ESPERITE N.V. (Euronext: ESP, "Esperite", "the Company" or "the Group") has published today its Annual Report for the year ended 31 December 2017. The 2017 Annual Report is [...]
Galapagos increases share capital through warrant exercises
23/11/2018
Mechelen, Belgium; 23 November 2018, 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase arising from warrant exercises. Galapagos issued 30,800 new ordinary [...]
Quantity of shares in Nexstim Plc after completion of the first phase in reducing the quantity of shares
23/11/2018
Company announcement, Helsinki, 23 November 2018 at 21:00 Quantity of shares in Nexstim Plc after completion of the first phase in reducing the quantity of shares The Extraordinary General Meeting of Nexstim Plc (NXTMH: [...]
Milestone Scientific Announces Recent Presentations Featuring The Wand® STA
23/11/2018
LIVINGSTON, N.J., Nov. 23, 2018 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced [...]
Abattis Bioceuticals Acquires Proprietary Genetic Strain Bank
23/11/2018
VANCOUVER, British Columbia, Nov. 23, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “ Company ” or “ Abattis ”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that it has entered into a definitive agreement (the [...]
Mandatory notification of trade
23/11/2018
Valborg Godal Vold, COO of Vistin Pharma ASA, and a primary insider, has on 18 September 2018 sold 50,000 shares in Vistin Pharma ASA at an average price of NOK 10.58 per share. Following this sale Valborg Godal Vold [...]
Oral semaglutide demonstrates favourable cardiovascular safety profile and significant reduction in cardiovascular death and all-cause mortality in people with type 2 diabetes in the PIONEER 6 trial
23/11/2018
Bagsværd, Denmark, 23 November 2018 - Novo Nordisk today announced the headline results from the last global phase 3a trial, PIONEER 6, for oral semaglutide, an investigational GLP-1 analogue taken once daily as a [...]
ATW Tech Increases Its Revenues by 24% for Revenues of $3.1 Million for Its Third Quarter of 2018
23/11/2018
MONTREAL, Nov. 23, 2018 (GLOBE NEWSWIRE) -- ATW Tech Inc. (the “Company”) (TSX-V: ATW) announces its financial results for its third quarter ended September 30, 2018. For its third quarter of 2018, the Company announced [...]
ATW Tech annonce des revenus en hausse de 24% pour 3,1 millions $ pour son troisième trimestre 2018
23/11/2018
MONTRÉAL, 23 nov. 2018 (GLOBE NEWSWIRE) -- ATW Tech Inc. (la « Société ») (TSX-V : ATW) annonce aujourd'hui ses résultats pour son troisième trimestre terminé le 30 septembre 2018. Pour son troisième trimestre 2018, la [...]
Aura Closes Strategic Investment Into HolyCanna, Bolstering International Strategy
23/11/2018
TORONTO, Nov. 23, 2018 (GLOBE NEWSWIRE) -- Aura Health Inc. (the " Company " or “ Aura ”) ( CSE:BUZZ ) is pleased to announce the closing of its previously announced letter of intent (“ LOI ”) to secure a majority (54 [...]
Aleafia Closes Transactions with Serruya Private Equity
23/11/2018
Transactions Positions Aleafia as Major Supplier, Retailer of Adult-use Cannabis TORONTO, Nov. 23, 2018 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSXV: ALEF; OTCQX: ALEAF, FRA: ARAH) (“Aleafia“ or the “Company“) is [...]
Aleafia to Release Q3 Results on November 26
23/11/2018
TORONTO, Nov. 23, 2018 (GLOBE NEWSWIRE) -- Aleafia Health Inc. ( TSXV: ALEF; OTCQX: ALEAF, FRA: ARAH ) (“ Aleafia “) or (the “ Company “), a highly differentiated cannabis company with major cannabis cultivation and [...]

Pages